Pharmaceuticals · Pharmaceuticals: Major · NSE: GUJTHEM · data 2026-10-30

Gujarat Themis Biosyn Ltd

₹363.2-3.35% on 30 OctHealth: Weak 3.7/10

Feb 2026Low ₹226.9 · High ₹453.25+12.1%

In plain words

Price: 23.0% below its 52-week high of ₹471.8.

Delivery: 49.6% of traded shares were kept for delivery over the last 10 sessions, against 53.0% over the last 60.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹363.2

Market cap

₹4,879 cr

P/E

81.3

P/B

—

ROE

17.4%

ROCE

18.2%

Debt / equity

0.56

Dividend yield

0.18%

1-year return

-21.9%

52-week high

₹471.8

52-week low

₹225.05

Operating margin

38.9%

Growth

Revenue (last 12 months)	₹174 cr
Net profit (last 12 months)	₹49 cr
Sales growth, 3 years (yearly)	3.8%
Profit growth, 3 years (yearly)	-7.0%

Smart-money activity

11/100 · Weak over the last ~60 sessions, data 2026-10-30

Delivery vs usual 0/30: Delivery 51.9% over the last 20 sessions vs 54.7% in the 40 before (0.95x); shares delivered per day 0.54x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
Bulk/block deals 0/20: Net −₹26.82 cr in bulk/block deals over 90 days (0 net buying days, 1 net selling day): more sold than bought.
Insider / SAST buys 6/15: 0 insider buy days (promoter group among them) and 1 SAST acquisition day in 90 days. Insider sells are not collected by the site, so only buy filings count.
Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
Promoter pledges 5/5: No promoter pledge filings in 90 days.

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Story so far

● Dividend ● Deal ● Insider

23 Sept 26Dividend Dividend ₹0.67 (ex-date) -0.3% next session
23 Sept 26Deal Bulk deal: L7 HITECH PRIVATE LIMITED sold ₹26.82 cr -0.3% next session
3 Sept 26Insider SAST disclosure: Pharmaceutical Business Group India… acquired shares -0.4% next session
4 Sept 25Dividend Dividend ₹0.67 (ex-date) -2.3% next session

From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.

Common questions

Is Gujarat Themis Biosyn Ltd debt-free?

Its latest reported debt-to-equity ratio is 0.56.

What is Gujarat Themis Biosyn Ltd's P/E ratio?

About 81.3, based on the last 12 months' earnings and a price of ₹363.2 (data 2026-10-30).

What is the 52-week high and low of Gujarat Themis Biosyn Ltd?

The 52-week high is ₹471.8 and the 52-week low is ₹225.05.

Similar companies

Senores Pharmaceuticals Ltd. (SENORES) · Orchid Pharma Limited (ORCHPHARMA) · RPG Life Sciences Limited (RPGLIFE) · SMS Pharmaceuticals Limited (SMSPHARMA) · Evonile Pharma Limited (NOVARTIND)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open GUJTHEM in NSE Scanner →